Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial

Orenstein WA(1986)Appropriate age for measles vaccination in the United States Dev Biol Stand 65 13-21

Markowitz L(2007)Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns Vaccine 25 6296-6304

Preblud SR(2018)Waning of measles maternal antibody in infants in measles elimination settings - a systematic literature review Vaccine 36 1248-1255

Hinman AR(1994)Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era Pediatrics 93 939-944

Tomasi A(1995)Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries BMJ 311 481-485

Bart KJ(2015)Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact Vaccine 33 237-245

Leuridan E(2014)Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections JAMA 311 826-835

Van Damme P(1991)The 1st International Standard for anti-measles serum Biologicals 19 237-241

Guerra FM(2019)BCG vaccination at birth and rate of hospitalization for infection until 15 months of age in Danish children: a randomized clinical multicenter trial J Pediatric Infect Dis Soc 8 213-220

Crowcroft NS(2014)Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age J Infect Dis 210 693-700

Orenstein WA(1986)Appropriate age for measles vaccination in the United States Dev Biol Stand 65 13-21

Markowitz L(2007)Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns Vaccine 25 6296-6304

Preblud SR(2018)Waning of measles maternal antibody in infants in measles elimination settings - a systematic literature review Vaccine 36 1248-1255

Hinman AR(1994)Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era Pediatrics 93 939-944

Tomasi A(1995)Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries BMJ 311 481-485

Bart KJ(2015)Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact Vaccine 33 237-245

Leuridan E(2014)Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections JAMA 311 826-835

Van Damme P(1991)The 1st International Standard for anti-measles serum Biologicals 19 237-241

Guerra FM(2019)BCG vaccination at birth and rate of hospitalization for infection until 15 months of age in Danish children: a randomized clinical multicenter trial J Pediatric Infect Dis Soc 8 213-220

Crowcroft NS(2014)Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age J Infect Dis 210 693-700